Bridget Croniger

Ms. Bridget Croniger

Wayne State University School of Medicine, Detroit, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMallika Somayajulu
Mallika Somayajulu
SMSharon McClellan
Sharon McClellan
RWRobert Emery Wright
Robert Emery Wright
APAhalya Pitchaikannu
Ahalya Pitchaikannu
BCBridget Croniger
Bridget Croniger
LHLinda D. Hazlett
Linda D. Hazlett
The purpose of this study is to test the effects of whole-body animal exposure to airborne particulate matter (PM) with an aerodynamic diameter of <10 μm (PM10) in the mouse cornea and in vitro. C57BL/6 mice were exposed to control or 500 µg/m3 PM10 for 2 weeks. In vivo, reduced glutathione (GSH) and malondialdehyde (MDA) were analyzed. RT-PCR and ELISA evaluated levels of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling and inflammatory markers. SKQ1, a novel mitochondrial antioxidant, was applied topically and GSH, MDA and Nrf2 levels were tested. In vitro, cells were treated with PM10 ± SKQ1 and cell viability, MDA, mitochondrial ROS, ATP and Nrf2 protein were tested. In vivo, PM10 vs. control exposure significantly reduced GSH, corneal thickness and increased MDA levels. PM10-exposed corneas showed significantly higher mRNA levels for downstream targets, pro-inflammatory molecules and reduced Nrf2 protein. In PM10-exposed corneas, SKQ1 restored GSH and Nrf2 levels and lowered MDA. In vitro, PM10 reduced cell viability, Nrf2 protein, and ATP, and increased MDA, and mitochondrial ROS; while SKQ1 reversed these effects. Whole-body PM10 exposure triggers oxidative stress, disrupting the Nrf2 pathway. SKQ1 reverses these deleterious effects in vivo and in vitro, suggesting applicability to humans.

21 September 2023 in Medical Science Educator
Verified
Journal Article
Closed access
PDF file
BCBridget Croniger
Bridget Croniger
MGMikaela Grudzien
Mikaela Grudzien
RIRubab Imtiaz
Rubab Imtiaz
DKDana Kabbani
Dana Kabbani
JMJennifer Mendez
Jennifer Mendez

11 February 2026 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
SGSarah Koopman Gonzalez
Sarah Koopman Gonzalez
SKSara Kennedy
Sara Kennedy
TWTyler A. West
Tyler A. West
KPKendall R. Pixley
Kendall R. Pixley
AWAndrea R. Waksmunski
Andrea R. Waksmunski
JBJessica Cooke Bailey
Jessica Cooke Bailey
Introduction: Vision impairment disproportionately affects individuals from low-income and African American communities, yet underutilization of preventive eye care persists. We conducted a community-based participatory research (CBPR) study to explore perceptions, values, and barriers related to vision care in an underserved urban neighborhood. Methods: In partnership with University Settlement, a trusted community center in Cleveland, Ohio, and a study-specific Community Advisory Board (CAB), we conducted semi-structured interviews with 60 adult residents of the Broadway-Slavic Village neighborhood. Thematic analysis identified key facilitators and barriers to accessing vision care. Results: Participants across racial groups described vision as highly important and often endorsed more frequent preventive eye care than they reported receiving. Barriers to eye care utilization included cost, inadequate insurance coverage, transportation challenges, fear of diagnosis, and limited awareness of preventive benefits. Distinct differences emerged in insurance type and visit frequency between African American and White participants despite comparable socioeconomic status. Participants identified community-specific solutions such as free or low-cost exams, mobile clinics, transportation support, and increased education. Conclusions: Our findings demonstrate that underutilization of eye care reflects structural and systemic barriers rather than lack of motivation. System-level interventions that integrate screenings into clinical and community settings, streamline referral pathways, and reduce logistical burdens are needed to facilitate equitable access to vision care. Embedding data collection in a trusted community setting surfaced perspectives from individuals who may be absent from clinic-based or online research and provides a model for translational research addressing health disparities.